tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Haemonetics raises FY24 adjusted EPS view to $3.90-$4.00 from $3.75-$3.95

Consensus $3.89. Raises FY24 revenue view to up 10%-12% from 8%-10%, consensus $1.27B. Cuts FY24 free cash flow to $160M-$180M from $170M-$190M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on HAE:

Disclaimer & DisclosureReport an Issue

1